The Promise and Pitfalls of Procalcitonin (PCT) in Antimicrobial Stewardship

10/12/2025 52 min
The Promise and Pitfalls of Procalcitonin (PCT) in Antimicrobial Stewardship

Listen "The Promise and Pitfalls of Procalcitonin (PCT) in Antimicrobial Stewardship"

Episode Synopsis

In this episode of the SHEA Podcast, host Dr. Jonathan Ryder moderates a lively pro/con debate on one of the most discussed biomarkers in infectious diseases: procalcitonin.

Joining the conversation are two experts with distinct perspectives: Dr. Michael Mansour, Clinician Investigator and Associate Professor of Infectious Diseases at Massachusetts General Hospital and Harvard Medical School, and Dr. Sheetal Kandiah, Senior Physician and Assistant Clinical Professor of Medicine in the Division of Infectious Diseases at Emory University; Director of the Antibiotic Stewardship Program at Grady Hospital.

Together, they explore where PCT may (or may not) add value in antimicrobial stewardship programs. Tune in for an insightful exchange that will help stewards, clinicians, and ID professionals better understand where PCT fits into today’s rapidly evolving diagnostic landscape.